Impact of Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Adenocarcinoma of the Body or Tail of the Pancreas

被引:0
作者
Yoshiaki Murakami
Kenichiro Uemura
Takeshi Sudo
Yasuo Hayashidani
Yasushi Hashimoto
Hiroki Ohge
Taijiro Sueda
机构
[1] Hiroshima University,Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences
来源
Journal of Gastrointestinal Surgery | 2009年 / 13卷
关键词
Pancreatic adenocarcinoma of the body or tail; Prognostic factor; Postoperative adjuvant chemotherapy; Gemcitabine; S-1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:85 / 92
页数:7
相关论文
共 160 条
[1]  
Murakami Y(2008)Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma J Gastrointest Surg 12 534-541
[2]  
Uemura K(2003)Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: A retrospective, single-institution experience Pancreas 26 243-249
[3]  
Sudo T(2006)Does postoperative chemotherapy have a survival benefit for patients with pancreatic cancer? J Surg Oncol 93 485-490
[4]  
Hayashidani Y(1996)Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer Pancreas 12 357-361
[5]  
Hashimoto Y(2004)Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma Br J Surg 91 586-594
[6]  
Ohge H(2000)Prognostic factors after surgical resection for pancreatic carcinoma J Surg Oncol 74 36-40
[7]  
Takai S(2005)Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas Am J Surg 189 278-282
[8]  
Satoi S(2000)Prognostic factors in the operative treatment of ductal pancreatic carcinoma Langenbecks Arch Surg 385 14-20
[9]  
Toyokawa H(2004)Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma Ann Surg Oncol 11 644-649
[10]  
Yanagimoto H(2006)Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma J Clin Oncol 24 2897-2902